Home/SAB Biotherapeutics/Theodore R. Heise

TR

Theodore R. Heise

Chief Medical Officer

SAB Biotherapeutics

Therapeutic Areas

Autoimmune Diseases Infectious Diseases

SAB Biotherapeutics Pipeline

Drug	Indication	Phase
SAB-142	Type 1 Diabetes	Phase 2
SAB-185	COVID-19 (SARS-CoV-2)	Phase 2/3
SAB-176	Influenza	Phase 1

Leadership Team at SAB Biotherapeutics

Samuel J. Reich

Chief Executive Officer

Eddie J. Sullivan

Co-Founder, President & Chief Operating Officer

Alexander G. Krouse

Chief Financial Officer

David P. Pearson

Chief Business Officer

Joseph M. Casper

Chief Scientific Officer

View full SAB Biotherapeutics profile